Immix Biopharma (IMMX) Other Non Operating Income (2021)
Immix Biopharma's (IMMX) quarterly Other Non Operating Income came in at $648830.0 in Q4 2021, up 820.92% quarter-over-quarter from -$90000.0 in Q2 2021.
Immix Biopharma (IMMX) Other Non Operating Income (2021) Analysis & Trends
Immix Biopharma has disclosed Other Non Operating Income across 1 years of filings, most recently posting $648830.0 for Q4 2021.
- Other Non Operating Income for Q4 2021 came in at $648830.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was -$266170.0 (changed N/A YoY), and the FY2021 annual result was -$86170.0, down 16930.08% from the prior year.
- Other Non Operating Income came in at $648830.0 for Q4 2021 at Immix Biopharma, up from -$90000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $648830.0 in Q4 2021 to a low of -$825000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 648,830.00 |
| Jun 30, 2021 | -90,000.00 |
| Mar 31, 2021 | -825,000.00 |